Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD
Advanced Science · 2026
DOI: 10.1002/advs.202508520 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Yuxin Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Dopaminergic Neurons, Ventral Tegmental Area, Ferroptosis, Autism Spectrum Disorder. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hainan Provincial Natural Science Foundation of China, Science and Technology Commission of Shanghai Municipality.
Abstract (Originalsprache)
Autism spectrum disorder (ASD) is a neurodevelopmental disorder, characterized by social dysfunction and stereotypic behavior, with the neuronal excitation/inhibition (E/I) imbalance as an underlying mechanism. The ultra‐short‐acting GABA‐A receptor agonist remimazolam has elicited unexpected long‐term improvements in agitation and cognition, suggesting a potential role in modulating the E/I imbalance. This study investigates the efficacy and mechanisms of remimazolam on ASD in a valproate (VPA)‐induced model. Intraperitoneal administration of remimazolam significantly ameliorates autistic‐like behaviors, with comparable effects caused by targeted injection of remimazolam into the ventral tegmental area (VTA). Chemogenetic inhibition of VTA dopaminergic neurons in VPA‐exposed mice reverses the therapeutic effects of remimazolam. Conversely, remimazolam also ameliorate the autistic‐like behaviors induced by chemogenetic inhibition. Remimazolam confers protection against VPA‐induced injury to VTA dopaminergic neurons both in vivo and in vitro by inhibiting ferroptosis, as evidenced by the reversal of its key hallmarks: mitochondrial damage, iron overload and lipid peroxidation. Furthermore, ferroptosis agonists reverse the therapeutic effect of remimazolam and ferroptosis inhibitors alleviate the autistic‐like behaviors. This study has demonstrated that remimazolam produces sustained alleviation of autistic‐like behaviors by inhibiting ferroptosis, indicating that ferroptosis may be a critical mechanism to its protection of VTA dopaminergic neurons and resultant behavioral improvement.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Oncology (Ward 2), Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Anesthesiology, Zhongshan Hospital, Fudan University, Shanghai, China.
ORCID-Profile: Yuxin Zhang, Jijian Zheng
Förderung
- Hainan Provincial Natural Science Foundation of China
- Science and Technology Commission of Shanghai Municipality
Zitieren
APA
Zhang, Y., Lin, J., Tong, C., Fu, X., Shan, M., Huang, Y., Zhang, K., & Zheng, J. (2026). Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD. Advanced Science. https://doi.org/10.1002/advs.202508520
Vancouver
Zhang Y, Lin J, Tong C, Fu X, Shan M, Huang Y, et al. Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD. Advanced Science. 2026. doi:10.1002/advs.202508520
BibTeX
@article{Zhang2026,
author = {Zhang, Yuxin and Lin, Jianwei and Tong, Chaoyang and Fu, Xin and Shan, Mengqin and Huang, Yue and Zhang, Kan and Zheng, Jijian},
title = {Remimazolam Ameliorates Autistic‐Like Behaviors via Suppression of Ferroptosis in VTA Dopaminergic Neurons in a Mouse Model of ASD},
journal = {Advanced Science},
year = {2026},
doi = {10.1002/advs.202508520}
}
EUVIMED